|Company name||PharMerica Corporation|
NEW YORK, August 3, 2017 – Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of PharMerica Corporation (NYSE: PMC) stockholders concerning the proposed acquisition of the company by KKR & Co. L.P. (NYSE: KKR) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA).
The investigation concerns whether PharMerica Corporation’s board of directors failed to adequately shop the Company and obtain the best possible value for PharMerica stockholders before entering into a definitive merger agreement with KKR and Walgreens Boots Alliance. Under the terms of the agreement, PharMerica Corporation stockholders will receive $29.25 in cash for each share of PharMerica common stock upon closing of the proposed transaction.
If you own PharMerica shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at email@example.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.